What Is Depakote ER? Uses, Dosage, and What You Need to Know in 2026

Depakote ER is a prescription medication that serves multiple purposes — it controls seizures, stabilizes mood in bipolar disorder, and prevents migraines. If you have been prescribed Depakote ER or are researching it for the first time, this guide covers everything patients need to know in 2026.

What Is Depakote ER?

Depakote ER is the brand name for divalproex sodium extended-release tablets, manufactured by AbbVie. The active ingredient, divalproex sodium, is a compound that the body metabolizes into valproic acid — the actual active form of the drug.

The "ER" stands for extended-release, meaning the tablet is coated to release medication slowly over the course of the day. This allows once-daily dosing, which is more convenient than the twice-daily or three-times-daily dosing required with Depakote DR (delayed-release) tablets.

Depakote ER was first approved by the FDA for extended-release formulation in 2000 and comes in two tablet strengths: 250 mg and 500 mg.

What Is Depakote ER Used For?

Depakote ER has three FDA-approved uses:

Epilepsy (seizure control): FDA-approved as monotherapy and adjunctive therapy for complex partial seizures (for adults and children 10 years and older) and for simple and complex absence seizures.

Bipolar disorder (acute mania): FDA-approved for treatment of acute manic or mixed episodes associated with bipolar I disorder. Depakote is often preferred over other mood stabilizers for patients with mixed episodes, rapid cycling, and euphoric mania.

Migraine prevention: FDA-approved for prophylaxis (prevention) of migraine headaches in adults. It is not effective for treating a migraine attack once it has started. The recommended dose for migraine is 500–1,000 mg once daily.

Off-label uses include bipolar disorder maintenance, aggression in schizophrenia (as an adjunct), and neuropathic pain, though these indications are less well-studied.

How Is Depakote ER Dosed?

Depakote ER is taken once daily, at the same time each day. Your doctor will determine your dose based on your condition, weight, and response. Here are typical dose ranges:

Epilepsy: Start at 10–15 mg/kg/day; increase by 5–10 mg/kg per week to effect; maximum 60 mg/kg/day. Target therapeutic level: 50–100 mcg/mL.

Bipolar disorder (acute mania): Start at 25 mg/kg/day; titrate rapidly to effect; maximum 60 mg/kg/day. Target trough: 85–125 mcg/mL.

Migraine prophylaxis: 500 mg once daily for 7 days, then increase to 1,000 mg once daily. Maximum 1,000 mg/day for migraine.

How to Take Depakote ER Correctly

Swallow whole. Depakote ER tablets must NOT be crushed, split, or chewed. This destroys the extended-release coating and releases the full dose at once, increasing side effects.

Take with or without food, but taking it with food can reduce nausea. Consistency is more important than timing with meals.

Take at the same time every day. Consistency in dosing time helps maintain stable blood levels.

Missed dose: Take the missed dose as soon as you remember, unless it is almost time for your next dose. Do not double up.

Never stop suddenly. Abrupt discontinuation can cause severe rebound seizures. Always taper under medical supervision.

Who Should Not Take Depakote ER?

Depakote ER is contraindicated (should not be used) in:

Patients with urea cycle disorders (UCD) — a group of inherited metabolic conditions

Patients with known mitochondrial disorders caused by POLG gene mutations (e.g., Alpers Huttenlocher Syndrome)

Children under 2 years with suspected mitochondrial disorders

Significant hepatic (liver) disease or dysfunction

Pregnant women or women of childbearing potential not using effective contraception (for migraine indication)

Is Depakote ER a Controlled Substance?

No. Depakote ER (divalproex sodium) is not a DEA-scheduled controlled substance. This means it can be prescribed by any licensed provider, prescribed via telehealth without special DEA authorization, filled by any licensed pharmacy, and obtained as a 90-day supply without restrictions.

Generic Version: Divalproex Sodium ER

A generic version of Depakote ER — divalproex sodium extended-release — is available from multiple manufacturers at significantly lower cost than the brand name. For most patients, the generic is clinically equivalent. For epilepsy patients, your neurologist may prefer you stay on a consistent formulation to maintain stable seizure control.

The Bottom Line

Depakote ER is a versatile, well-established medication for epilepsy, bipolar disorder, and migraine prevention. Taken correctly with appropriate monitoring, it is effective for most patients. If you have difficulty finding Depakote ER in stock, medfinder can help. For more on what to expect from the medication, see our article on Depakote ER side effects.